Studying at the University of Verona
Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.
Study Plan
This information is intended exclusively for students already enrolled in this course.If you are a new student interested in enrolling, you can find information about the course of study on the course page:
Combined Bachelor's + Master's degree in Pharmacy - Enrollment from 2026/2027The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.
1° Year
| Modules | Credits | TAF | SSD |
|---|
2° Year activated in the A.Y. 2024/2025
| Modules | Credits | TAF | SSD |
|---|
3° Year activated in the A.Y. 2025/2026
| Modules | Credits | TAF | SSD |
|---|
4° Year It will be activated in the A.Y. 2026/2027
| Modules | Credits | TAF | SSD |
|---|
5° Year It will be activated in the A.Y. 2027/2028
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
Legend | Type of training activity (TTA)
TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.
Pharmacovigilance and Pharmacoepidemiology (2026/2027)
Teaching code
4S011757
Academic staff
Credits
6
Language
Italian
Scientific Disciplinary Sector (SSD)
BIO/14 - PHARMACOLOGY
Period
Primo semestre 2026/2027 dal Oct 5, 2026 al Dec 23, 2026.
Courses Single
Not Authorized
Learning objectives
The aim of this course is to provide elements on the use, effectiveness and safety of drugs through pharmacovigilance and pharmacoepidemiology.
At the end of the course the students will know: the National and European legislation on pharmacovigilance; the Italian National Health Service: pharmaceutical assistance; the methodologies for the quantitative and qualitative monitoring of drugs; the application of epidemiological methodologies on the use of drugs; the main mechanisms of side effects, adverse drug reactions (ADRs) and risk factors; ADR spontaneous reporting system and prescribing appropriateness; healthcare utilization databases; strengths and limitations of the spontaneous reporting systems; drug-drug interactions; pharmacovigilance in special populations (e.g., children, elderly, pregnant women); vaccines pharmacovigilance; risk management plan; PSUR; PASS and PAES studies;
reliable sources for drug information; the concepts and methodologies used to carry out pharmacoepidemiology studies; confounders, biases, including exposure and outcome misclassification; to write a study protocol and to interpret study results in pharmacoepidemiology and pharmacovigilance.
Prerequisites and basic notions
Knowledge of basic and clinical pharmacology
Program
Pharmacoepidemiology Module: Introduction to pharmacoepidemiology, different types of real-world data and general principles of real-world evidence, totality of evidence, observational study designs (case-control studies, cohort and cross-sectional studies, case-only studies), definition and management of confounding factors and bias, critical reading of observational studies. Pharmacovigilance Module: Introduction to Pharmacovigilance, Adverse Drug Reactions (ADRs): classification and terminology, Spontaneous reporting of ADRs, Causality assessment, International databases, disproportionality analysis, Generation and management of safety signals, PASS and PAES studies in pharmacovigilance and risk minimization measures, Active pharmacovigilance and sentinel systems, Pharmacovigilance in special populations – Pregnancy and breastfeeding, Pediatrics and Geriatrics, Pharmacovigilance in clinical drug trials, Lessons from the history of pharmacovigilance: thalidomide, diethylstilbestrol, rofecoxib, cerivastatin. cisapride, Vaccine Pharmacovigilance (vaccinovigilance), Risk Communication in PV
Bibliography
Didactic methods
Frontal lessons
Learning assessment procedures
Oral exam with a question on Pharmacoepidemiology and one on Pharmacovigilance
Evaluation criteria
Grade expressed out of thirtieths. The assessment takes into account both the concepts illustrated during the lessons and the technical language skills and the ability to make connections on topics that cut across the various lessons.
Exam language
italiano